Some age-associated illnesses are associated with poorer physical
function in HIV-positive patients when compared to HIV-negative people, US investigators report in the January
edition of AIDS Patient Care and STDs.
The investigators compared physical
function in HIV-positive and HIV-negative patients of the same age. Most of the
study participants were aged over 50, which the investigators emphasise is “a
frequently used benchmark to designate older HIV-infected adults.”
Results showed that there was a steeper annual decline in
physical function among HIV-positive patients than HIV-negative individuals.
However the difference was only modest – a 50-year-old HIV-positive patient had
the same level of physical function as an HIV-negative individual aged 52.
Nevertheless, the investigators comment, “the magnitude of
the rate of decline in function…was greater in HIV-infected patents.”
Some of the diseases common in older age were associated
with poorer physical function in those with HIV.
Studies conducted before effective antiretroviral therapy
was introduced showed that many patients with advanced HIV disease had poor
physical function.
Although rates of serious HIV-related illnesses have fallen
in recent years, there is concern that patients with HIV may have an increased
risk cardiovascular disease, obstructive pulmonary disease, and low bone
mineral density. In HIV-negative patients these diseases of ageing are
associated with poorer physical function, which in turn is a risk factor for a
higher risk of death.
Therefore investigators from the US Department of Veterans
Affairs Aging Cohort Study (VACS) undertook research to compare physical
function in HIV-positive and HIV-negative patients, and to see if age-related
illness were associated with associated with deterioration in patients physical
functioning.
A total of 3227
HIV-positive and 3240 HIV-negative individuals were recruited to the study
between 2002 and 2006. Approximately 50% of HIV-positive patients were aged 50
or above. Individuals completed questionnaires enquiring ability to attend to
their day-to-day physical needs, work, and exercise.
Information was also gathered on the patients’ demographics
and health, and this showed that over 80% of the HIV-positive patients were
taking antiretroviral therapy and approximately 25% had a CD4 cell count above
500 cells/mm3.
There were important differences between the two groups of
patients. Fewer patients with HIV were aged over 55 (27% vs. 32%) and
individuals with HIV were less likely than those who were HIV-negative to have
been diagnosed with heart failure, coronary heart disease, hypertension,
chronic pulmonary disease, vascular disease or stroke. However, HIV-positive
patients exercised less frequently, especially those aged over 55 (p = 0.05).
Overall 35% of patients reported no problems with their
physical function, and better functioning was associated with greater frequency
of exercise.
During the study 18% of HIV-positive patients and 7% of
HIV-negative individuals died. Poor physical function almost doubled the risk
of death (hazard ratio [HR] = 1.96; 95% confidence interval [CI], 1.60-2.39).
After taking into consideration demographic differences and
clinical factors such as the presence of co-morbid conditions, the
investigators found that physical function was significantly poorer in patients
with HIV (p = 0.02).
When HIV-positive and HIV-negative individuals were
compared, those with HIV had a greater annual decline in physical function.
Comparison by age group showed that younger HIV-positive
patients (under 44) had better physical function than HIV-negative individuals
(p < 0.01). But this was reverse for those aged over 55 (p < 0.01).
Further analysis showed that the average 50-year-old
HIV-positive patient has the same level of physical function as an HIV-negative
individual aged 51.5 year.
Cardiovascular disease and hypertension was associated with
similar declines in physical function for both HIV-positive and HIV-negative
patients.
For patients with chronic obstructive pulmonary disease,
infection with HIV was associated with poorer functioning. “A 50-year old
HIV-infected subject had the equivalent level of function as a 68.1-year old
uninfected subject.”
The investigators suggest that this could be because of
accelerated disease progression or longer duration of illness in patients with
HIV. “The results support an aging interaction driven by comorbidity that
warrants further investigation,” comment the investigators.
They also believe the relationship between chromic pulmonary
disease and poorer physical function had implications fort the care of
HIV-positive patients, especially the provision of support to stop smoking.
But in some instances, HIV-positive patients had better physical functioning. These included diabetes. A 50-year-old HIV-positive patient with this condition had the same level of physical function as a 36-year-old HIV-negative diabetic patient.
"The majority of HIV-infected VACS participants receive
combination antiretroviral therapy and have high CD4 cell counts,” write the
investigators, “our findings demonstrate that age-related comorbidity should be
considered an important risk factor for poor physical function in this
setting.” They conclude, “the study supports further integration of primary
health care and provision into HIV care with increased focus on age-associated
comorbidity.”